Effects of a Suspension Training Warm-up on Cardiopulmonary Exercise Performance

NCT ID: NCT07215052

Last Updated: 2025-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-15

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will compare two warm-up methods before cardiopulmonary exercise testing (CPET) in recreationally active young adults. Participants will complete treadmill walking or TRX suspension warm-up, followed by a treadmill exercise test to exhaustion. The investigators to determine whether suspension warm-up produces similar peak oxygen uptake (VO2max) and cardiopulmonary responses as treadmill walking.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CPET is the gold standard for assessing aerobic fitness. Warm-up procedures may influence outcomes. Traditional CPET warm-up uses walking or cycling, but suspension training provides a dynamic, full-body option. This randomized, counterbalanced crossover study will compare VO₂max and secondary outcomes (time to exhaustion, HRmax, RER, VE, BP, VT) after treadmill vs suspension training warm-up. The primary analysis is a non-inferiority test with a 5% margin for VO₂max.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Exercise Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

open label

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1: Walking Warm-up (WW)

6 min treadmill walking at comfortable pace, 0% incline.

Group Type ACTIVE_COMPARATOR

Walking Warm-up

Intervention Type OTHER

6 minutes treadmill walking at comfortable self-selected pace, 0% incline.

Suspension Warm-up (SW)

6 min dynamic TRX warm-up (reverse lunges, squats, jump squats, rows, push-ups).

Group Type EXPERIMENTAL

Suspension Training Warm-up

Intervention Type OTHER

6 minutes TRX suspension warm-up (reverse lunges 45s, squats 60s, jump squats 45s, rows 30s, push-ups 30s, with 30s rests).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Walking Warm-up

6 minutes treadmill walking at comfortable self-selected pace, 0% incline.

Intervention Type OTHER

Suspension Training Warm-up

6 minutes TRX suspension warm-up (reverse lunges 45s, squats 60s, jump squats 45s, rows 30s, push-ups 30s, with 30s rests).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Aged 19 to 25 years

Engages in ≥5 hours per week of moderate-to-vigorous physical activity (classified as "high activity" based on the International Physical Activity Questionnaire \[ICIQ\])

Able to pass the Physical Activity Readiness Questionnaire (PAR-Q+) screening

Exclusion Criteria

Participates in \<5 hours per week of moderate-to-vigorous physical activity

Contraindications to maximal cardiopulmonary exercise testing or suspension training

Presence of any medical condition that may interfere with safe test participation or data interpretation

\-
Minimum Eligible Age

19 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tamara Rial-Faigenabum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tamara Rial-Faigenabum

Principal Investigator, Coordinator Human Performance Lab and Specialist Professor Monmouth Unversity

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Monmouth University Graduate Center Room 222

West Long Branch, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SP2553

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.